IRBEZYD H 150/12.5 TABLETS (IRBESARTAN 150MG + HYDROCHLOROTHIAZIDE 12.5MG)

TZS 10,000

In stock

IRBEZYD H 150/12.5 IS A COMBINATION ANTIHYPERTENSIVE MEDICINE CONTAINING IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE 12.5MG. IRBESARTAN IS AN ANGIOTENSIN II RECEPTOR BLOCKER THAT RELAXES BLOOD VESSELS, WHILE HYDROCHLOROTHIAZIDE IS A THIAZIDE DIURETIC THAT HELPS THE BODY ELIMINATE EXCESS SODIUM AND WATER THROUGH URINE. THE COMBINATION PROVIDES EFFECTIVE BLOOD PRESSURE CONTROL IN PATIENTS WHO REQUIRE MORE THAN ONE MEDICINE TO MANAGE HYPERTENSION. IT HELPS REDUCE THE RISK OF CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH UNCONTROLLED HIGH BLOOD PRESSURE. POSSIBLE SIDE EFFECTS INCLUDE DIZZINESS, INCREASED URINATION, DEHYDRATION AND ELECTROLYTE IMBALANCES. KIDNEY FUNCTION AND ELECTROLYTES SHOULD BE MONITORED AS APPROPRIATE. THIS MEDICINE MUST NOT BE USED DURING PREGNANCY.

IRBEZYD H 150/12.5 IS A COMBINATION ANTIHYPERTENSIVE MEDICINE CONTAINING IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE 12.5MG. IRBESARTAN IS AN ANGIOTENSIN II RECEPTOR BLOCKER THAT RELAXES BLOOD VESSELS, WHILE HYDROCHLOROTHIAZIDE IS A THIAZIDE DIURETIC THAT HELPS THE BODY ELIMINATE EXCESS SODIUM AND WATER THROUGH URINE. THE COMBINATION PROVIDES EFFECTIVE BLOOD PRESSURE CONTROL IN PATIENTS WHO REQUIRE MORE THAN ONE MEDICINE TO MANAGE HYPERTENSION. IT HELPS REDUCE THE RISK OF CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH UNCONTROLLED HIGH BLOOD PRESSURE. POSSIBLE SIDE EFFECTS INCLUDE DIZZINESS, INCREASED URINATION, DEHYDRATION AND ELECTROLYTE IMBALANCES. KIDNEY FUNCTION AND ELECTROLYTES SHOULD BE MONITORED AS APPROPRIATE. THIS MEDICINE MUST NOT BE USED DURING PREGNANCY